BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Morbach C, Buck T, Rost C, Peter S, Günther S, Störk S, Prettin C, Erbel R, Ertl G, Angermann CE; On Behalf of the Handheld-BNP Research Network. Point-of-care B-type natriuretic peptide and portable echocardiography for assessment of patients with suspected heart failure in primary care: rationale and design of the three-part Handheld-BNP program and results of the training study. Clin Res Cardiol 2018;107:95-107. [DOI: 10.1007/s00392-017-1181-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Martocchia A, Bentivegna E, Sergi D, Luciani M, Barlattani M, Notarangelo MF, Piccoli C, Sesti G, Martelletti P. The Point-of-Care Ultrasound (POCUS) by the Handheld Ultrasound Devices (HUDs) in the COVID-19 Scenario: a Review of the Literature. SN Compr Clin Med 2022;5:1. [DOI: 10.1007/s42399-022-01316-9] [Reference Citation Analysis]
2 Matthes A, Bleidorn J, Markwart R. Research on point-of-care tests in outpatient care in Germany: A scoping review and definition of relevant endpoints in evaluation studies. Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen 2022. [DOI: 10.1016/j.zefq.2022.06.002] [Reference Citation Analysis]
3 Castro-Portillo E, López-Izquierdo R, Sanz-García A, Ortega GJ, Delgado-Benito JF, Castro Villamor MA, Sánchez-Soberón I, Del Pozo Vegas C, Martín-Rodríguez F. Role of prehospital point-of-care N-terminal pro-brain natriuretic peptide in acute life-threatening cardiovascular disease. Int J Cardiol 2022:S0167-5273(22)00923-8. [PMID: 35716940 DOI: 10.1016/j.ijcard.2022.06.025] [Reference Citation Analysis]
4 Rintz E, Węgrzyn G, Fujii T, Tomatsu S. Molecular Mechanism of Induction of Bone Growth by the C-Type Natriuretic Peptide. Int J Mol Sci 2022;23:5916. [PMID: 35682595 DOI: 10.3390/ijms23115916] [Reference Citation Analysis]
5 Hoevelmann J, Muller E, Azibani F, Kraus S, Cirota J, Briton O, Ntsekhe M, Ntusi NAB, Sliwa K, Viljoen CA. Prognostic value of NT-proBNP for myocardial recovery in peripartum cardiomyopathy (PPCM). Clin Res Cardiol 2021;110:1259-69. [PMID: 33555408 DOI: 10.1007/s00392-021-01808-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
6 Andersen CA, Hedegård HS, Løkkegaard T, Frølund J, Jensen MB. Education of general practitioners in the use of point-of-care ultrasonography: a systematic review. Fam Pract 2021;38:484-94. [PMID: 33367766 DOI: 10.1093/fampra/cmaa140] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
7 Deek H, Newton PJ, Kabbani S, Hassouna B, Macdonald PS, Davidson PM. The Lebanese Heart Failure Snapshot: A National Presentation of Acute Heart Failure Admissions. Journal of Nursing Scholarship 2020;52:506-14. [DOI: 10.1111/jnu.12583] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Lewis RA, Durrington C, Condliffe R, Kiely DG. BNP/NT-proBNP in pulmonary arterial hypertension: time for point-of-care testing? Eur Respir Rev 2020;29:200009. [PMID: 32414745 DOI: 10.1183/16000617.0009-2020] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 11.5] [Reference Citation Analysis]
9 Wasser K, Weber-krüger M, Gröschel S, Uphaus T, Liman J, Hamann GF, Kermer P, Seegers J, Binder L, Gelbrich G, Gröschel K, Wachter R. Brain Natriuretic Peptide and Discovery of Atrial Fibrillation After Stroke: A Subanalysis of the Find-AF RANDOMISED Trial. Stroke 2020;51:395-401. [DOI: 10.1161/strokeaha.119.026496] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 12.0] [Reference Citation Analysis]
10 Yang J, Wang K, Xu H, Yan W, Jin Q, Cui D. Detection platforms for point-of-care testing based on colorimetric, luminescent and magnetic assays: A review. Talanta 2019;202:96-110. [PMID: 31171232 DOI: 10.1016/j.talanta.2019.04.054] [Cited by in Crossref: 87] [Cited by in F6Publishing: 91] [Article Influence: 29.0] [Reference Citation Analysis]
11 Bielecka-Dabrowa A, Godoy B, Suzuki T, Banach M, von Haehling S. Subclinical hypothyroidism and the development of heart failure: an overview of risk and effects on cardiac function. Clin Res Cardiol 2019;108:225-33. [PMID: 30091084 DOI: 10.1007/s00392-018-1340-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
12 Sramko M, Wichterle D, Melenovsky V, Franekova J, Clemens M, Fukunaga M, Kautzner J. Independent effect of atrial fibrillation on natriuretic peptide release. Clin Res Cardiol 2019;108:142-9. [DOI: 10.1007/s00392-018-1332-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
13 Lachowska K, Bellwon J, Narkiewicz K, Gruchała M, Hering D. Long-term effects of device-guided slow breathing in stable heart failure patients with reduced ejection fraction. Clin Res Cardiol 2019;108:48-60. [PMID: 29943271 DOI: 10.1007/s00392-018-1310-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
14 Bauer A, Khalil M, Lüdemann M, Bauer J, Esmaeili A, De-rosa R, Voelkel NF, Akintuerk H, Schranz D. Creation of a restrictive atrial communication in heart failure with preserved and mid-range ejection fraction: effective palliation of left atrial hypertension and pulmonary congestion. Clin Res Cardiol 2018;107:845-57. [DOI: 10.1007/s00392-018-1255-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]